CHLORPROMAZINE hydrochloride, eq. 25mg base, tab.

STD DORACHLM2T-

Valid Article

24.1 - Medicines for psychotic disorders
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05AA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Substance listed as Narcotic Drug or Psychotropic Substance, and as precursors. Other substances may be subject to restrictions according to national regulations. These substances require an import permit from the country of destination when ordering.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

CHLORPROMAZINE

Therapeutic Action

Sedative antipsychotic

Indications

Acute or chronic psychosis

Alternative to haloperidol in case of extrapyramidal effects

Alternative to risperidone and/or olanzapine if not available

Instructions for use

Do not crush tablets (risk of contact dermatitis).

In some countries, chlorpromazine is on the list of narcotics: follow national regulations. (Cf Introduction: Narcotic and psychotropic medicines under international control)

Precautions for Use

Do not administer in patients with cardiac disorders, dementia, closed-angle glaucoma, prostate disorders, Parkinson's disease and history of neuroleptic malignant syndrome.

Administer with caution and carefully monitor use in elderly patients and patients with hypokalaemia, hypotension, renal or hepatic impairment, history of seizures.

Storage

Below 25°C - Protect from sunlight - Protect from humidity